Generic placeholder image

Mini-Reviews in Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 1389-5575
ISSN (Online): 1875-5607

Rhenium-188 and Copper-67 Radiopharmaceuticals for the Treatment of Bladder Cancer

Author(s): M. Frier

Volume 4, Issue 1, 2004

Page: [61 - 68] Pages: 8

DOI: 10.2174/1389557043487510

Price: $65

Abstract

The favourable nuclear properties of copper-67 and rhenium-188 for therapeutic application are described, together with methods for the chemical synthesis of a number of derivatives. Survival from invasive bladder cancer has changed little over the past 20 years. The intravesicular administration of Cu-67 or Re-188 radiopharmaceuticals in the treatment of bladder cancer offers some promise for improvement in this situation.

Keywords: Rhenium-188, Copper-67, Bladder, Cancer, Radioimmunotherapy


Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy